Ligand Pharmaceuticals reported $11.16M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Amgen USD 3.01B 406M Jun/2025
Baxter International USD 1.82B 55M Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Eli Lilly USD 2.45B 223.6M Jun/2025
Gilead Sciences USD 1.5B 39M Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Glaxosmithkline GBP 2.16B 363M Jun/2025
Insmed USD 29.34M 8.06M Jun/2025
Ionis Pharmaceuticals USD 4.15M 3.15M Jun/2025
Ligand Pharmaceuticals USD 11.16M 6.32M Jun/2025
MacroGenics USD 49.7M 44.21M Jun/2025
Merck USD 2.82B 53M Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Veracyte USD 41.02M 6.05M Jun/2025